Trial Outcomes & Findings for Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy (NCT NCT04547023)

NCT ID: NCT04547023

Last Updated: 2022-11-21

Results Overview

Number of positive GDM screen (\>= 140 mg/dL) on the 1 hour 50-g oral glucose tolerance test conducted between 24-28 weeks gestation This outcome was assessed in pregnant participants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

200 participants

Primary outcome timeframe

Day of GDM screen (occurring between 24-28 weeks gestation)

Results posted on

2022-11-21

Participant Flow

This study enrolled pregnant participants. While outcomes were assessed in neonates, they were not considered to be enrolled.

Participant milestones

Participant milestones
Measure
Fasting Before Gestational Diabetes Screen
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Overall Study
STARTED
100
100
Overall Study
COMPLETED
96
97
Overall Study
NOT COMPLETED
4
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Fasting Before Gestational Diabetes Screen
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Overall Study
Did Not Receive Intervention
3
2
Overall Study
Lost to Follow-up
1
1

Baseline Characteristics

Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fasting Before Gestational Diabetes Screen
n=100 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=100 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Total
n=200 Participants
Total of all reporting groups
Age, Continuous
32.2 years
STANDARD_DEVIATION 4.2 • n=5 Participants
33.2 years
STANDARD_DEVIATION 4.7 • n=7 Participants
32.7 years
STANDARD_DEVIATION 4.5 • n=5 Participants
Sex: Female, Male
Female
100 Participants
n=5 Participants
100 Participants
n=7 Participants
200 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian/ Pacific Islander
39 Participants
n=5 Participants
35 Participants
n=7 Participants
74 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic
6 Participants
n=5 Participants
17 Participants
n=7 Participants
23 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic White
49 Participants
n=5 Participants
40 Participants
n=7 Participants
89 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
4 Participants
n=5 Participants
5 Participants
n=7 Participants
9 Participants
n=5 Participants
Region of Enrollment
United States
100 Participants
n=5 Participants
100 Participants
n=7 Participants
200 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)

Population: Participants who completed the 1 hour GDM screen are included in the analysis

Number of positive GDM screen (\>= 140 mg/dL) on the 1 hour 50-g oral glucose tolerance test conducted between 24-28 weeks gestation This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants With a Positive Gestational Diabetes Mellitus (GDM) Screen (>= 140 mg/dL) on the 1 Hour 50-g Oral Glucose Tolerance Test (OGTT)
31 Participants
13 Participants

SECONDARY outcome

Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)

Population: Participants who completed the 1 hour GDM screen are included in the analysis

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Mean Gestational Age at OGTT Screen
25.7 weeks
Standard Deviation 1.2
25.8 weeks
Standard Deviation 1.3

SECONDARY outcome

Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)

Population: Participants who completed the 1 hour GDM screen are included in the analysis

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Mean Glucose Level at the OGTT Screen
127.7 mg/dL
Standard Deviation 35.8
113.3 mg/dL
Standard Deviation 26.4

SECONDARY outcome

Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)

Population: Participants who completed the 1 hour GDM screen are included in the analysis

This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants With Positive GDM Diagnosis Based on the OGTT
8 Participants
2 Participants

SECONDARY outcome

Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)

Population: Participants who completed the 1 hour GDM screen are included in the analysis

Average number of hours since the participant's last oral intake prior to OGTT screen

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Average Time of Last Oral Intake Prior to the OGTT Screen
10.7 hours
Standard Deviation 3.0
1.4 hours
Standard Deviation 0.9

SECONDARY outcome

Timeframe: Day of OGTT (occurring at 24-28 weeks gestation up to 42 weeks gestation)

Population: Participants who completed the 1 hour GDM screen are included in the analysis

GDM diagnosis based on 1-hour OGTT ≥ 180 mg/dL or 2 elevated values on the 3-hour OGTT using Carpenter and Coustan criteria. This outcome was assessed in pregnant participants Carpenter and Coustan Criteria is as follows (if 2 or more values are elevated, this is gestational diabetes): * Fasting glucose \< 95; * One hour glucose \< 180; * Two hour glucose \< 155; * Three hour glucose \< 140

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants With Positive GDM Diagnosis
12 Participants
5 Participants

SECONDARY outcome

Timeframe: At time of delivery (Up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Mean Gestational Age at Delivery
272 days
Standard Deviation 12
272 days
Standard Deviation 10

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Who Delivered Vaginally
67 Participants
53 Participants

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Who Delivered Via Operative Vaginal Birth
3 Participants
7 Participants

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Who Delivered Vaginally After a Prior Cesarean Section
2 Participants
1 Participants

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

Primary = first Cesarean section for participant. This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Who Delivered Via a Primary Cesarean Section
17 Participants
21 Participants

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Who Delivered Via a Repeat Cesarean Section
7 Participants
14 Participants

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

Shoulder dystocia is a birth injury (also called birth trauma) that happens when one or both of a baby's shoulders get stuck inside the mother's pelvis during labor and birth. This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Complicated by Shoulder Dystocia at Delivery
0 Participants
1 Participants

SECONDARY outcome

Timeframe: At time of delivery (up to 42 weeks' gestation)

Population: Participants who had delivery data are included in the analysis.

A third degree tear is a tear or laceration through the perineal muscles and the anal sphincter. A fourth degree tear goes through the anal sphincter all the way to the anal canal or rectum. This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Complicated by Third or Fourth Degree Perineal Laceration
2 Participants
4 Participants

SECONDARY outcome

Timeframe: Up to 6 weeks after delivery

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants after delivery.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants With Post-partum Hemorrhage
16 Participants
10 Participants

SECONDARY outcome

Timeframe: From time of GDM screen up to 6 weeks after delivery

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Diagnosed With a Hypertensive Disorder of Pregnancy
22 Participants
15 Participants

SECONDARY outcome

Timeframe: Up to 1 week after delivery

Population: Participants who had delivery data are included in the analysis.

Average number of days admitted in the hospital after delivery up to discharge

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Length of Postnatal Stay From Delivery to Discharge
2.3 days
Standard Deviation 0.9
2.4 days
Standard Deviation 1.1

SECONDARY outcome

Timeframe: From initial hospital discharge up to 6 weeks post-partum

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants post-delivery.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants Who Had a Postpartum Readmission
4 Participants
6 Participants

SECONDARY outcome

Timeframe: From time of delivery up to 6 weeks post-partum

Population: Participants who had delivery data are included in the analysis.

This outcome was assessed in pregnant participants after delivery.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Participants With Type 2 Diabetes Mellitus Diagnosis Post-partum
1 Participants
0 Participants

SECONDARY outcome

Timeframe: Day of delivery (Within approximately 2 hours after delivery)

Population: Participants with a live birth are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Mean Neonatal Birthweight
3231 grams
Standard Deviation 631
3268 grams
Standard Deviation 458

SECONDARY outcome

Timeframe: Day of delivery (Within approximately 2 hours after delivery)

Population: Participants with a live birth are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates With Birth Weight More Than 4000 Grams
6 neonates
6 neonates

SECONDARY outcome

Timeframe: Day of delivery (Within approximately 2 hours after delivery)

Population: Participants with a live birth are included in the analysis.

LGA refers to neonatal birth weight larger than the 90th percentile for gestational age.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates Considered Large for Gestational Age (LGA)
6 neonates
7 neonates

SECONDARY outcome

Timeframe: Day of delivery (Within approximately 2 hours after delivery)

Population: Participants with a live birth are included in the analysis.

SGA are infants whose weight is \< the 10th percentile for gestational age.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates Considered Small for Gestational Age (SGA)
6 neonates
9 neonates

SECONDARY outcome

Timeframe: Up to 28 days after delivery

Population: Participants with a live birth are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates Admitted to the Neonatal Intensive Care Unit (NICU)
4 neonates
7 neonates

SECONDARY outcome

Timeframe: Up to 28 days after delivery

Population: Participants with a live birth are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates With Hyperbilirubinemia
7 neonates
9 neonates

SECONDARY outcome

Timeframe: Up to 28 days after delivery

Population: Participants with a live birth are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates With Hypoglycemia
9 neonates
5 neonates

SECONDARY outcome

Timeframe: Up to 28 days after delivery

Population: Participants with a live birth are included in the analysis.

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates Diagnosed With Respiratory Distress Syndrome
7 neonates
7 neonates

SECONDARY outcome

Timeframe: Up to 28 days after delivery

Population: Participants with breast feeding data are included in the analysis

Outcome measures

Outcome measures
Measure
Fasting Before Gestational Diabetes Screen
n=86 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=88 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Number of Neonates Exclusively Breastfeeding at Time of Hospital Discharge
62 neonates
59 neonates

Adverse Events

Fasting Before Gestational Diabetes Screen

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

Fed Before Gestational Diabetes Screen

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Fasting Before Gestational Diabetes Screen
n=100 participants at risk
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
Fed Before Gestational Diabetes Screen
n=100 participants at risk
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
Pregnancy, puerperium and perinatal conditions
Intrauterine fetal demise
1.0%
1/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
0.00%
0/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
Congenital, familial and genetic disorders
Congenital anomaly
1.0%
1/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
0.00%
0/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)

Other adverse events

Adverse event data not reported

Additional Information

Yair Blumenfeld, MD

Stanford University

Phone: 650-498-4069

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place